candesartan cilexetil has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 1 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, L | 1 |
| Tian, YY | 1 |
| Shi, JP | 1 |
| Xie, W | 1 |
| Shi, JQ | 1 |
| Lu, J | 1 |
| Zhang, YD | 1 |
1 other study available for candesartan cilexetil and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
Inhibition of endoplasmic reticulum stress is involved in the neuroprotective effects of candesartan cilexitil in the rotenone rat model of Parkinson's disease.
Topics: Animals; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Disease Models, Animal; Dopaminergic N | 2013 |